[Effect of medroxyprogesterone (MPA) on blood levels of FSH, LH and prolactin in women].
D000328:Adult; D004715:Endometriosis / Q000188:drug therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood*; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D010048:Ovarian Cysts / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011388:Prolactin / Q000097:blood*
D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Wpływ medroksyprogesteronu (MPA) na stezenie FSH, LH i prolaktyny we krwi u kobiet.